Feb 13, 2025

1m, Inc. Initiative equips providers with critical data and intelligence to navigate shifting federal policies on healthcare funding, reimbursement and eligibility More than fifteen health systems engaged in the first week NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- 1m, a data and analytics technology company serving the risk management needs of healthcare organizations, today announced the launch of a national standardized risk assessment to help healthcare providers stay ahead of critical changes in federal healthcare policy. The initiative will include leading healthcare providers across the country to provide an objective and data-based analysis of emerging risks and their potential impact. More than fifteen health systems are already engaged and preparing to participate. The assessment will be made available to participating healthcare providers. Interested parties can contact intelligence@1mplatform.com to inquire about participating. "Health systems are scrambling to assess the flurry of policy shifts and emerging risks independently,” said Chris Giuliano, co-CEO and CTO of 1m. “We’ve seen this reactive cycle before—in response to COVID-19, cybersecurity threats, and inflation. It’s time to break the cycle. This intelligence network will standardize risk assessments and help providers align on responsive strategies.” 1m will survey a consortium of health systems to create an anonymized national healthcare risk dataset. That data will be used to create standardized reports and executive-ready guidance for risk managers, business leaders and boards. The initial assessments will focus on the recent policy changes proposed by Congress and the new administration, and their potential impact on providers, e.g. : Medicaid funding cuts and eligibility requirements Medicare funding cuts and drug pricing negotiations Reductions related to the Affordable Care Act (ACA) Inflationary pressures as a result of new tariffs Cuts in funding for public health agencies Impact of immigration policy on staffing All participating health systems will have access to the in-depth, data-driven outputs, including: Consensus risk assessments